Skip to content

US · AGL · MEDICAL - CARE FACILITIES

Agilon Health, Inc. (AGL) intrinsic value and stock valuation

$90.24as of 2026-11-21 · Mkt cap 1.59B

Data updated · price as of 2026-11-21

Strongly overvaluedIC value is more than 50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Agilon Health, Inc. DCF and intrinsic value

InvestorsCraft values AGL with the Chepakovich two-stage DCF model — currently rated strongly overvalued. How the model works · Run your own DCF prefilled from AGL’s statements →

Agilon Health, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Care Facilities Westerville, OH 43082 agilonhealth.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$5.93B+37.2% 5y CAGRd
20192025
Net income
-$-405.35M
20192025
Free cash flow
-$-119M
20192025
Total equity
$126.7M
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$5.93B$6.06B$4.32B$2.39B$1.52B
Operating income-$-421.08M-$-292.13M-$-232.13M-$-105.38M-$-372.24M
Net income-$-405.35M-$-260.15M-$-262.6M-$-106.55M-$-406.49M
EPSd-$-24.48M-$-15.82M-$-16.05M-$-6.52M-$-27.24M
Operating cash flow-$-105.76M-$-57.78M-$-156.2M-$-130.81M-$-148.16M
Capital expenditure-$-13.24M-$-13.25M-$-30.82M-$-32.66M-$-13.43M
Free cash flow-$-119M-$-71.03M-$-187.01M-$-163.47M-$-161.59M
Total assets$1.27B$1.73B$1.74B$1.7B$1.59B
Total debt$36.8M$44M$52.3M$52.6M$59.6M
Net debt-$-136.9M-$-149.9M-$-62.02M-$-412.73M-$-995.21M
Total equity$126.7M$471M$661M$1.04B$1.09B
Cash and short-term investments$285.1M$405.6M$495.1M$877.2M$1.05B
Income statement
20252024202320222021
Revenue$5.93B$6.06B$4.32B$2.39B$1.52B
Cost of revenue$6.12B$6.06B$4.25B$2.28B$1.46B
Gross profit-$-188.61M$4.84M$69.7M$111.4M$65.7M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$238.5M$268.9M$285.8M$207.8M$427.5M
Other expenses-$-6.08M$28.1M$16M$8.95M$10.5M
Operating expenses$232.5M$297M$301.8M$216.7M$438M
Cost and expenses$6.35B$6.35B$4.55B$2.49B$1.89B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$6.64M$6.18M$6.66M$4.48M$6.15M
Depreciation and amortization$28.6M$24.5M$20.2M$13.8M$14.7M
Ebitda-$-368.86M-$-218.19M-$-167.64M-$-72.41M-$-362.16M
Operating income-$-421.08M-$-292.13M-$-232.13M-$-105.38M-$-372.24M
Total other income/expenses, net$17M$43.3M$37.7M$14.7M-$-10.73M
Income before tax-$-404.1M-$-248.83M-$-194.46M-$-90.67M-$-382.98M
Income tax expense$1.25M$1.45M$790K$1.64M$890K
Net income-$-405.35M-$-260.15M-$-262.6M-$-106.55M-$-406.49M
Weighted average shares outstanding$16.6M$16.4M$16.4M$16.3M$14.9M
Weighted average diluted shares outstanding$16.6M$16.4M$16.4M$16.3M$14.9M
Balance sheet
20252024202320222021
Cash and short-term investments$285.1M$405.6M$495.1M$877.2M$1.05B
Net receivables$673.8M$1.02B$942.5M$492.4M$293.4M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$1.1B$1.46B$1.48B$1.45B$1.37B
Property, plant and equipment, net$25.4M$37M$41M$32M$20.9M
Goodwill and intangible assets$65.7M$96.9M$87.9M$21M$96.9M
Long-term investments$59.8M$61.8M$44.8M$17.4M$6.69M
Total non-current assets$174.6M$276.2M$260.8M$246.2M$219.1M
Total assets$1.27B$1.73B$1.74B$1.7B$1.59B
Accounts payable$1.06B$1.15B$968.1M$478.2M$348.7M
Short-term debt$19.2M$2.46M$9.1M$5M$8.31M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$1.08B$1.15B$977.2M$535.1M$357M
Long-term debt$17.6M$41.5M$43.2M$47.6M$51.3M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$68.1M$111M$102.7M$121.8M$137.7M
Capital lease obligations$1.83M$6.6M$10.9M$9.09M$7.9M
Total liabilities$1.14B$1.26B$1.08B$656.9M$494.7M
Common stock$4.15M$4.12M$4.06M$4.12M$4M
Retained earnings-$-1.98B-$-1.59B-$-1.33B-$-1.06B-$-957.68M
Accumulated other comprehensive income (loss)$920K-$-90K-$-2.3M-$-5.56M$0.00
Total equity$126.7M$471M$661M$1.04B$1.09B
Total investments$171.2M$273.5M$425.5M$429.3M$6.69M
Total debt$36.8M$44M$52.3M$52.6M$59.6M
Net debt-$-136.9M-$-149.9M-$-62.02M-$-412.73M-$-995.21M
Cash flow statement
20252024202320222021
Net income-$-391.35M-$-260.1M-$-262.8M-$-106.86M-$-406.79M
Depreciation and amortization$28.6M$24.5M$20.2M$13.8M$14.7M
Stock-based compensation$49.1M$50.7M$69.3M$28.4M$292.4M
Change in working capital$189.5M$130.6M-$-10.07M-$-59.44M-$-55.02M
Accounts receivable$344.6M-$-74.58M$0.00-$-204.17M-$-149.04M
Inventory$0.00$0.00$0.00$0.00$149M
Accounts payable-$-87.48M$198.6M$473.6M$173.5M$95.7M
Net cash provided by operating activities-$-105.76M-$-57.78M-$-156.2M-$-130.81M-$-148.16M
Investments in property, plant and equipment-$-13.24M-$-13.25M-$-15.83M-$-15.43M-$-13.43M
Acquisitions, net$0.00$0.00-$-43.06M$500K-$-1.34M
Net cash used for investing activities$88.6M$139.9M-$-44.02M-$-444.39M-$-90.51M
Common stock issued$0.00$1.17M$11.9M$33.1M$1.19B
Common stock repurchased-$-2.99M$0.00-$-200M$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-2.99M-$-2.58M-$-193.13M$28.1M$1.15B
Net change in cash-$-20.15M$79.5M-$-393.35M-$-547.14M$915.7M
Cash at end of period$173.7M$193.9M$114.3M$507.7M$1.05B
Operating cash flow-$-105.76M-$-57.78M-$-156.2M-$-130.81M-$-148.16M
Capital expenditure-$-13.24M-$-13.25M-$-30.82M-$-32.66M-$-13.43M
Free cash flow-$-119M-$-71.03M-$-187.01M-$-163.47M-$-161.59M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Agilon Health, Inc.

        Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.

        CEO
        Timothy O'Rourke
        Employees
        856
        Beta
        3.00

        Explore

        Frequently asked questions

        What is the intrinsic value of Agilon Health, Inc. (AGL)?

        Agilon Health, Inc. (AGL) is currently strongly overvalued based on the InvestorsCraft IC model — IC value is more than 50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is AGL undervalued?

        AGL trades at a price of $90.24 (Nov 21, 2026): strongly overvalued — IC value is more than 50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.